Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP

Metabolic Syndrome (MetS) constitutes of metabolic abnormalities that lead to non-communicable diseases, such as type II diabetes, cardiovascular diseases, and cancer. Early and accurate diagnosis of this abnormality is required to prevent its further progression to these diseases. This paper aims t...

Full description

Bibliographic Details
Main Authors: Kakudi, Habeebah Adamu, Loo, Chu Kiong, Moy, Foong Ming, Masuyama, Naoki, Pasupa, Kitsuchart
Format: Article
Published: Institute of Electrical and Electronics Engineers 2019
Subjects:
_version_ 1825722196167753728
author Kakudi, Habeebah Adamu
Loo, Chu Kiong
Moy, Foong Ming
Masuyama, Naoki
Pasupa, Kitsuchart
author_facet Kakudi, Habeebah Adamu
Loo, Chu Kiong
Moy, Foong Ming
Masuyama, Naoki
Pasupa, Kitsuchart
author_sort Kakudi, Habeebah Adamu
collection UM
description Metabolic Syndrome (MetS) constitutes of metabolic abnormalities that lead to non-communicable diseases, such as type II diabetes, cardiovascular diseases, and cancer. Early and accurate diagnosis of this abnormality is required to prevent its further progression to these diseases. This paper aims to diagnose the risk of MetS using a new non-clinical approach called 'genetically optimized Bayesian adaptive resonance theory mapping' (GOBAM). We evolve the Bayesian adaptive resonance theory mapping (BAM) by using genetic algorithm to optimize the parameters of BAM and its training input sequence. We use the GOBAM algorithm to classify individuals as either being at risk of MetS or not at risk of MetS with a related posterior probability, which ranges between 0 and 1. A data set of 11 237 Malaysians from the CLUSTer study stratified by age and gender into four subcategories was used to evaluate the proposed GOBAM algorithm. The comparative evaluation of our results suggested that the GOBAM performs significantly better than other classical adaptive resonance theory mapping models on the area under the receiver operating characteristic curves (AUC) and others criteria. Our algorithm gives an AUC of 86.42 %, 87.04 %, 91.08 %, and 89.24 % for the young female, middle aged female, young male, and middle-aged male subcategories, respectively. The proposed model can be used to support medical practitioners in accurate and early diagnosis of MetS. © 2013 IEEE.
first_indexed 2024-03-06T06:01:57Z
format Article
id um.eprints-24155
institution Universiti Malaya
last_indexed 2024-03-06T06:01:57Z
publishDate 2019
publisher Institute of Electrical and Electronics Engineers
record_format dspace
spelling um.eprints-241552020-04-06T15:35:53Z http://eprints.um.edu.my/24155/ Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP Kakudi, Habeebah Adamu Loo, Chu Kiong Moy, Foong Ming Masuyama, Naoki Pasupa, Kitsuchart QA75 Electronic computers. Computer science R Medicine Metabolic Syndrome (MetS) constitutes of metabolic abnormalities that lead to non-communicable diseases, such as type II diabetes, cardiovascular diseases, and cancer. Early and accurate diagnosis of this abnormality is required to prevent its further progression to these diseases. This paper aims to diagnose the risk of MetS using a new non-clinical approach called 'genetically optimized Bayesian adaptive resonance theory mapping' (GOBAM). We evolve the Bayesian adaptive resonance theory mapping (BAM) by using genetic algorithm to optimize the parameters of BAM and its training input sequence. We use the GOBAM algorithm to classify individuals as either being at risk of MetS or not at risk of MetS with a related posterior probability, which ranges between 0 and 1. A data set of 11 237 Malaysians from the CLUSTer study stratified by age and gender into four subcategories was used to evaluate the proposed GOBAM algorithm. The comparative evaluation of our results suggested that the GOBAM performs significantly better than other classical adaptive resonance theory mapping models on the area under the receiver operating characteristic curves (AUC) and others criteria. Our algorithm gives an AUC of 86.42 %, 87.04 %, 91.08 %, and 89.24 % for the young female, middle aged female, young male, and middle-aged male subcategories, respectively. The proposed model can be used to support medical practitioners in accurate and early diagnosis of MetS. © 2013 IEEE. Institute of Electrical and Electronics Engineers 2019 Article PeerReviewed Kakudi, Habeebah Adamu and Loo, Chu Kiong and Moy, Foong Ming and Masuyama, Naoki and Pasupa, Kitsuchart (2019) Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP. IEEE Access, 7. pp. 8437-8453. ISSN 2169-3536, DOI https://doi.org/10.1109/ACCESS.2018.2880224 <https://doi.org/10.1109/ACCESS.2018.2880224>. https://doi.org/10.1109/ACCESS.2018.2880224 doi:10.1109/ACCESS.2018.2880224
spellingShingle QA75 Electronic computers. Computer science
R Medicine
Kakudi, Habeebah Adamu
Loo, Chu Kiong
Moy, Foong Ming
Masuyama, Naoki
Pasupa, Kitsuchart
Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title_full Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title_fullStr Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title_full_unstemmed Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title_short Diagnosing Metabolic Syndrome Using Genetically Optimised Bayesian ARTMAP
title_sort diagnosing metabolic syndrome using genetically optimised bayesian artmap
topic QA75 Electronic computers. Computer science
R Medicine
work_keys_str_mv AT kakudihabeebahadamu diagnosingmetabolicsyndromeusinggeneticallyoptimisedbayesianartmap
AT loochukiong diagnosingmetabolicsyndromeusinggeneticallyoptimisedbayesianartmap
AT moyfoongming diagnosingmetabolicsyndromeusinggeneticallyoptimisedbayesianartmap
AT masuyamanaoki diagnosingmetabolicsyndromeusinggeneticallyoptimisedbayesianartmap
AT pasupakitsuchart diagnosingmetabolicsyndromeusinggeneticallyoptimisedbayesianartmap